BeStock  
Stocks › Biotechnology › BCAX

Bicara Therapeutics BCAX

US equityMarket cap rank #3530Biotechnology
$8.44 −$0.68 (-7.46%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $8.44 0.00%
Open$8.83
Prev close$9.12
Day range$8.43 – $9.14
Volume814.5K
Market cap$560.31M
P/E (TTM)–
Dividend yield–

Price chart

Daily bars for up to one year, weekly bars for the 5-year view. Averages are 50/200 trading days (10/40 weeks on the 5-year view). Triangles mark past earnings reports, colored by that day’s move; ticks mark ex-dividend dates — hover either for the date. Volume is the shaded bars under the price; switch on RSI or MACD above for a full-history oscillator panel, or Bollinger Bands for the same 20-day/2-standard-deviation channel used in the Technical signals table.

BCAX at a glance

BCAX is priced at $8.44 right now, down 7.46% on the session. That puts its market value at $560.31M, 3530th largest among the 3753 stocks we cover.

It is close to the bottom of its 52-week range ($7.87 to $30.99), 72.8% under the high. Holders are behind 53.2% over twelve months, and down 64.2% across the last three months.

On the chart it has slipped under both the 50-day ($15.43) and 200-day ($20.65) moving averages; RSI is 28, which some call oversold, and the last 30 sessions moved at roughly 189% annualized volatility.

For the quarter ended Sep 2026 it reported $0.00 in revenue, and a net loss of $71.25M.

8 analysts follow the stock and the average call is "buy". The mean target, $31.63, sits 274.8% over where the stock trades.

This summary is put together from the numbers on the page and updates when they do. It describes the data; it is not a forecast or a recommendation.

Key statistics

Bid / Ask$8.44 / $10.22
Average price today$8.66
Volume814.5KAvg (90d) 1.03M
Turnover$7.06M
Turnover rate2.22%of shares outstanding
Volume ratio0.72vs. recent average pace
Day amplitude7.79%
Market cap$560.31M
Float market cap$310.27M
Shares outstanding36.76M
EPS (TTM)-$2.52
P/B1.37
Book value / share$6.17
Net profit (TTM)-$167.30M
Net assets$409.41M
30-day volatility189.3%annualized
Avg daily range (ATR)9.76%of price, 14 days
Max drawdown (1y)-73.9%-72.2% from 1y peak

Quote as of Nov 20, 2026 8:10 pm ET. Prices can lag the live tape. This is background information, not a recommendation.

BeStock Grade

F
BeStock Grade

Composite of 3 factors below, ranked against the 3734 U.S. stocks BeStock covers.

F
Valuation

Cheaper than usual on its own 5-year P/E history scores higher.

F
Momentum

Trading closer to its 52-week high than most peers scores higher.

B
Wall Street

8 analysts, consensus Buy.

How this is scored: each factor above is a 0–100 percentile rank against every other stock BeStock covers (or, for Wall Street, against the five-point Strong Buy–Sell scale). The overall grade is the plain average of whichever factors apply to this stock — no factor is weighted more than another. That average maps to a letter: A ≥ 85, B ≥ 70, C ≥ 50, D ≥ 30, otherwise F. Recomputed from the data on this page as prices and filings update — it describes where a stock ranks today, not a forecast, and not a BeStock recommendation to buy or sell.

Six-factor research snapshot

Overall percentile: 22.5 · 2026-11-22 08:27 UTC. Higher values indicate a stronger relative ranking.

FactorPercentile
Valuation—
Growth—
Profitability5.9
Momentum5.3
Financial health78.6
Analyst view93.7

Price forecast

What Wall Street analysts and Morningstar's fair-value model expect for the stock

Analyst price target (avg)$31.63+274.8% vs. current price
Consensus ratingBuy8 analysts covering
Morningstar fair value$14.97Price is below fair value

Wall Street’s average 12-month target is $31.63, 274.8% above today’s price, with a consensus rating of Buy. Morningstar’s fair value model puts the stock at $14.97, so shares trade 43.6% below that estimate. On earnings multiple, it sits in the 98th percentile of its own five-year valuation range (pricier than usual).

Figures are Wall Street analyst consensus and Morningstar’s independent fair-value model, sourced as noted above.

Performance

Price return over each window, from adjusted daily and weekly closes

1 day
-7.5%
1 week
-15.8%
1 month
-52.1%
3 months
-64.2%
6 months
-61.1%
Year to date
-49.9%
1 year
-53.2%
Day range
$8.43$9.14
52-week range
$7.87$30.99

Technical signals

Full technicals →
Trend readStrong downtrend

1 bullish · 5 bearish of 7 signals

IndicatorValueSignal
Price vs 20-day average-16.7%Bearish
Price vs 50-day average-45.3%Bearish
Price vs 200-day average-59.1%Bearish
50-day vs 200-day50d below 200dBearish
RSI (14)28.2Neutral
MACD (12,26,9)-1.89Bullish
Bollinger band position33%Bearish

Standard indicator readings worked out from daily closes. They describe how the price has behaved, not where it is going.

How BCAX ranks on BeStock

Market value#3512 of 3734
Closeness to 52-week high#3546 of 3724
Dollar volume today#2566 of 3734

Ranks are among the 3,734 or so U.S.-listed stocks BeStock covers, recalculated whenever prices refresh. A tile is left out when the measure does not apply, such as yield for a stock that pays no dividend.

BCAX is not currently one of the 10 holdings in BeStock Momentum, our rules-based momentum strategy.

Since 2020-12-28, the strategy has returned 401.7% (183.6% for the equal-weight average of BeStock’s coverage over the same stretch). Holdings can change any trading day, not just on a fixed schedule. Backtested performance, updated daily — not a guarantee of future results, and not a BeStock recommendation.

Strategy Backtest

Pick a strategy above and run the backtest to see its simulated performance on BCAX.

Rule-based technical strategies computed from this stock’s own price history only. Signals use only data available through the prior trading day (no look-ahead), and trading costs, slippage and taxes aren’t modeled. A backtested rule performing well in the past is not a guarantee of future results — this is an educational illustration, not investment advice.

Community Sentiment on BCAX

No votes yet — be the first to weigh in.

Reader sentiment, not investment advice. One vote per visitor; click again to change it.

BCAX stock: common questions

Where is BCAX trading right now?

$8.44 is the latest print for BCAX, a move of -7.46% against yesterday's close of $9.12. Today's low and high so far: $8.43 and $9.14.

What is BCAX worth in total?

Equity value comes to $560.31M at the current price. By that measure it is number 3530 of the 3753 names in our coverage.

Where does BCAX sit in its 52-week range?

The year's floor is $7.87 and the ceiling $30.99. Shares are 72.8% away from that ceiling.

Does BCAX send cash back through a dividend?

Our data shows no dividend paid by Bicara Therapeutics over the trailing twelve months.

Do Wall Street analysts like BCAX?

Of 8 analysts, 88% say buy, 0% hold and 13% sell. Price targets average $31.63, with the most cautious at $8.00 and the most optimistic at $43.00.

BeStock publishes market data and analysis for information only. Nothing here is investment advice or a solicitation to buy or sell any security, and none of it is tailored to your financial situation, goals, or risk tolerance. Quotes may be delayed and figures can contain errors; check primary sources before you trade. How we source and calculate these pages.

Discussion

No comments yet — be the first to weigh in on BCAX.

Sign in to join the discussion.

Scroll to Top